Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023 - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Media  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library

    • Our 2023 Integrated Annual Report is live!

       Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Presentations
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Share-Price Data
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers – 2
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category
    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
        < Back
      • Company
      • History
      • Fondation Ipsen
  • Science
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
        < Back
      • Science
      • Pipeline
    • Clinical Trials
  • Responsibility
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Stories
  • New Home Page
Back

Post navigation

Previous
Next

Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023

Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023

- 01 June 2023 - 0 mins read

Post navigation

Previous
Next

Related Documents

  • Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023   Download  (132 KB)

Related Reports and Accounts

Information relating to compensation elements of Mr. David Loew, CEO – 31 May 2023
02 June 2023 0 mins read

Information relating to compensation elements of Mr. David Loew, CEO – 31 May 2023
2022 Integrated Annual Report
31 May 2023 1 mins read

2022 Integrated Annual Report
2022 Universal Registration Document
06 April 2023 1 mins read

2022 Universal Registration Document
Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer
09 February 2023 0 mins read

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer
2021 Integrated Annual Report
31 May 2022 0 mins read

2021 Integrated Annual Report
Information relating to compensation elements
25 May 2022 0 mins read

Information relating to compensation elements
Compensation policy for corporate officers, result of vote SM
25 May 2022 0 mins read

Compensation policy for corporate officers, result of vote SM
2021 Universal Registration Document
14 April 2022 0 mins read

2021 Universal Registration Document
Information relating to compensation elements
28 May 2021 0 mins read

Information relating to compensation elements
Compensation policy for corporate officers, result of vote SM
28 May 2021 0 mins read

Compensation policy for corporate officers, result of vote SM

IPN price

€101.90

 €-1.10 (-1.07%)

  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy
  • Company
  • Responsibility
  • Patients
  • Stories
  • Annual Report
  • Contact us
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website.
To continue, please click on Continue?

Continue
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.